Pivotal trial found the enfortumab vedotin plus pembrolizumab combination significantly extended overall and progression-free survival
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
The matter of Arbitration between Shilpa Medicare Limited and Celltrion towards supply and distribution agreement
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
Hearing restoration was observed within 30 days of a single administration of AK-OTOF in the initial AK-OTOF-101 study participant
Febuxostat Tablets (RLD Uloric) had estimated annual sales of US$ 27 million in the U.S. (IQVIA MAT November 2023)
Collaboration streamlines patient access to oncology clinical trials
Sonoma will manufacture Ocudox by Avenova with packaging similar to NovaBay’s Avenova products
A 'better for you' organic brand spanning Food & Beverages and Nutraceutical categories
Submission based on positive results from global phase 3 study demonstrating overall survival benefit of TIVDAK over chemotherapy
Subscribe To Our Newsletter & Stay Updated
